Trial · NCT06215222
Capsule Microbiota Sampling in IBS/Functional Gastrointestinal Disease
We will sample intestinal microbiota using a microbiome sampling capsule in Healthy, Irritable Bowel Syndrome (IBS), and Functional Gastrointestinal Disease.
- Status
- Recruiting
- Sponsor
- Stanford University
- Study type
- Observational
- Phase
- Not applicable
- Enrollment
- 40 participants (planned)
- Start
- Nov 16, 2023
- Primary completion
- Dec 1, 2025
- Conditions
- IBS - Irritable Bowel Syndrome, Healthy, Functional Bloating, Functional Gastrointestinal Disorders
Summary
We will sample intestinal microbiota using a microbiome sampling capsule in Healthy, Irritable Bowel Syndrome (IBS), and Functional Gastrointestinal Disease.
Interventions
- Microbiota Sampling Other
Locations
1 country: United States.
| Facility | City | Country |
|---|---|---|
| Stanford Digestive Health Clinic | Redwood City, California | United States |
TreatIBS is an informational site and does not provide medical advice. The research summarized here may not apply to your situation. Talk with a clinician before starting, stopping, or changing any treatment.
Listing only. Eligibility is decided by the study team. TreatIBS is not involved in recruitment.